ProteoSense, LLC, a Columbus-based spinout of The Ohio State University, is the most recent recipient of an investment from the $1 million Technology Concept Fund, LLC. The Technology Concept Fund includes capital committed by The Ohio State University and Ohio Third Frontier and is managed by Rev1 Ventures.

ProteoSense is developing a unique sensor technology invented by Ohio State College of Engineering and College of Medicine researchers to detect proteins that are fundamental markers of pathogens such as Salmonella, E-coli, and Listeria. The firm is focusing initially on detecting serious threats to food safety in fresh produce.

Read more on the Rev1 Ventures blog here.